Searchable abstracts of presentations at key conferences in endocrinology

ea0032p491 | Diabetes | ECE2013

Advantages of using DPP-4 inhibitors in patients with type 2 diabetes mellitus and overweight

Rodriguez Jose Perez , Portillo Cristobal Morales , Pena Ignacio Fernandez , Olmedo Isabel Serrano , Mayor Maria del Carmen De la Cuesta , Perez Angel Sendon

Objective: Analyze the use of DPP-4 inhibitors (iDPP4) in a specialized consultation as well as metabolic impact, weight and safety in patients with diabetes mellitus type 2 (DM2).Material and methods: We analyzed 100 patients with DM2, derivative to Diabetes hospital with debut or poor glycemic control. We initiated them sitagliptin 100 mg/day and reinforced Diabetes education. We studied the HbA1c, weight and severe hypoglycemia. Statistical analysis w...